Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore F Reiss

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Controlled Clinical Trials|April 12, 2002
Quality assurance of asthma clinical trialsKerstin Malmstrom, Iza Peszek, Al Botto, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 23, 2017
Adverse events are rare after single-dose montelukast exposures in childrenDonald H Arnold, Nena Bowman, Theodore F Reiss, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 25, 2007
Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukastGeorge Philip, Cesar Villarán, David S Pearlman, et al.
American Journal of Respiratory and Critical Care Medicine|November 29, 2002
A randomized controlled trial of intravenous montelukast in acute asthmaCarlos A Camargo, Howard A Smithline, Marie-Pierre Malice, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|May 7, 2011
The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthmaGeorge Philip, César Villarán, Shailen R Shah, et al.
Journal of Clinical Pharmacology|September 22, 2020
Pilot Study of Peak Plasma Concentration After High-Dose Oral Montelukast in Children With Acute Asthma ExacerbationsDonald H Arnold, Sara L Van Driest, Theodore F Reiss, et al.
Current Medical Research and Opinion|June 23, 2005
Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthmaJanet van Adelsberg, James Moy, Lynn X Wei, et al.
The Journal of Urology|November 7, 2006
Efficacy and safety of a neurokinin-1 receptor antagonist in postmenopausal women with overactive bladder with urge urinary incontinenceStuart A Green, Achilles Alon, Juliana Ianus, et al.
The Journal of Allergy and Clinical Immunology|October 10, 2009
Reports of suicidality in clinical trials of montelukastGeorge Philip, Carolyn Hustad, Gertrude Noonan, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 7, 2019
Adverse events associated with weight-based, high-dose montelukast exposures in childrenDonald H Arnold, Nena Bowman, Theodore F Reiss, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Controlled Clinical Trials|April 12, 2002
Quality assurance of asthma clinical trialsKerstin Malmstrom, Iza Peszek, Al Botto, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 23, 2017
Adverse events are rare after single-dose montelukast exposures in childrenDonald H Arnold, Nena Bowman, Theodore F Reiss, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 25, 2007
Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukastGeorge Philip, Cesar Villarán, David S Pearlman, et al.
American Journal of Respiratory and Critical Care Medicine|November 29, 2002
A randomized controlled trial of intravenous montelukast in acute asthmaCarlos A Camargo, Howard A Smithline, Marie-Pierre Malice, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|May 7, 2011
The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthmaGeorge Philip, César Villarán, Shailen R Shah, et al.
Journal of Clinical Pharmacology|September 22, 2020
Pilot Study of Peak Plasma Concentration After High-Dose Oral Montelukast in Children With Acute Asthma ExacerbationsDonald H Arnold, Sara L Van Driest, Theodore F Reiss, et al.
Current Medical Research and Opinion|June 23, 2005
Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthmaJanet van Adelsberg, James Moy, Lynn X Wei, et al.
The Journal of Urology|November 7, 2006
Efficacy and safety of a neurokinin-1 receptor antagonist in postmenopausal women with overactive bladder with urge urinary incontinenceStuart A Green, Achilles Alon, Juliana Ianus, et al.
The Journal of Allergy and Clinical Immunology|October 10, 2009
Reports of suicidality in clinical trials of montelukastGeorge Philip, Carolyn Hustad, Gertrude Noonan, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 7, 2019
Adverse events associated with weight-based, high-dose montelukast exposures in childrenDonald H Arnold, Nena Bowman, Theodore F Reiss, et al.
Pageof 6